eess.IVMar 25, 2026

Beyond Benchmarks: A Framework for Post Deployment Validation of CT Lung Nodule Detection AI

Authors: Daniel Soliman

Abstract

Background: Artificial intelligence (AI) assisted lung nodule detection systems are increasingly deployed in clinical settings without site-specific validation. Performance reported under benchmark conditions may not reflect real-world behavior when acquisition parameters differ from training data. Purpose: To propose and demonstrate a physics-guided framework for evaluating the sensitivity of a deployed lung nodule detection model to systematic variation in CT acquisition parameters. Methods: Twenty-one cases from the publicly available LIDC-IDRI dataset were evaluated using a MONAI RetinaNet model pretrained on LUNA16 (fold 0, no fine-tuning). Five imaging conditions were tested: baseline, 25% dose reduction, 50% dose reduction, 3 mm slice thickness, and 5 mm slice thickness. Dose reduction was simulated via image-domain Gaussian noise; slice thickness via moving average along the z-axis. Detection sensitivity was computed at a confidence threshold of 0.5 with a 15 mm matching criterion. Results: Baseline sensitivity was 45.2% (57/126 consensus nodules). Dose reduction produced slight degradation: 41.3% at 25% dose and 42.1% at 50% dose. The 5 mm slice thickness condition produced a marked drop to 26.2% - a 19 percentage point reduction representing a 42% relative decrease from baseline. This finding was consistent across confidence thresholds from 0.1 to 0.9. Per-case analysis revealed heterogeneous performance including two cases with complete detection failure at baseline. Conclusion: Slice thickness represents a more fundamental constraint on AI detection performance than image noise under the conditions tested. The proposed framework is reproducible, requires no proprietary scanner data, and is designed to serve as the basis for ongoing post-deployment QA in resource-constrained environment.

Explore similar work

May 1, 2026

Reconstruction Interval Z-Phase Dependence of AI Detection Sensitivity in CT Lung Nodule Screening

Background: Sensitivity of AI-assisted lung nodule detection systems is known to vary with CT acquisition parameters including radiation dose, reconstruction kernel, and slice thickness. However, the dependence of detection probability on nodule position within the reconstruction cycle -- the z-phase -- has not, to the author's knowledge, been characterized for deep learning-based detection systems. Methods: A retrospective analysis was performed using the LIDC-IDRI dataset. Detection results from a previously validated 154-case perturbation study were re-analyzed. For each consensus nodule (>=4-reader agreement), z-phase was defined as the fractional position of the nodule center within the reconstruction cycle, folded to [0, 0.5]. Detection sensitivity was stratified by z-phase bin, reconstruction interval (1mm, 3mm, 5mm), and by the ratio of reconstruction interval to nodule diameter (d/D). Results: At 5mm reconstruction interval, sensitivity was 71.6% vs 84.8% at 1mm baseline. Within the 5mm condition, sensitivity varied by 17.6 percentage points across z-phase bins. Stratified by d/D ratio, sensitivity was 92.4% for d/D < 0.5, 78.0% for 0.5 <= d/D < 1.0, and 61.4% for d/D >= 1.0, with a systematic z-phase effect present only in the d/D >= 1.0 stratum. Conclusions: AI detection sensitivity depends on the ratio of reconstruction interval to nodule diameter. When this ratio approaches or exceeds 1.0 -- as occurs for 3-6mm nodules at 5mm reconstruction -- z-phase becomes the dominant source of per-study detection variance. This stochastic effect is invisible to protocol-level quality metrics and not reflected in AI confidence scores.
Jun 11, 2026

Acquisition state behaves as a structured, measurable variable governing lung-nodule AI: kernel-driven measurement instability and noise-driven detection fragility, invisible to DICOM metadata

AI governance for medical imaging is formalizing: the 2026 ACR-SIIM Practice Parameter recommends local acceptance testing and ongoing drift monitoring, and the ACR Assess-AI registry monitors AI outputs using DICOM metadata for context. We argue that a necessary, currently unmonitored layer sits beneath output metrics: whether incoming studies remain within the acquisition envelope a model was validated on. Using a LUNA16-trained MONAI RetinaNet lung-nodule detector, we test whether acquisition state behaves as a structured, measurable variable. On real paired CT differing only in reconstruction kernel (NLST B30f vs B80f), kernel alone shifted AI-measured diameter and flipped a Fleischner size category in 5.2% (8 of 155) of nodules at fixed patient and acquisition, while detection confidence was unchanged (Wilcoxon p=0.22). Under controlled LIDC-IDRI perturbations the effects dissociated by axis: the noise axis degraded detection confidence (p=5.9e-32, concentrated in nodules under 6 mm) but not measurement, while the frequency/kernel axis corrupted measurement (p=8.6e-13) but not detection. A 4-feature pixel fingerprint recovered reconstruction identity (patient-level AUC about 0.95 on real CT, 0.995 on a QIBA phantom) where the ConvolutionKernel DICOM tag was uninformative (identical labels across reconstructions). The kernel axis transported across four manufacturers (leave-one-vendor-out AUC 0.94-0.98, matching the within-vendor ceiling). Acquisition state thus maps to distinct AI failure modes, frequency content to measurement reliability and noise to detection sensitivity, and is not recoverable from metadata. Acquisition-aware, input-side validation is the missing layer for the acceptance-testing and drift-monitoring requirements now entering imaging-AI accreditation.
May 14, 2026

How Sensitive Are Radiomic AI Models to Acquisition Parameters?

A main barrier for the deployment of AI radiomic systems in clinical routine is their drop in performance under heterogeneous multicentre acquisition protocols. This work presents a performance-oriented framework for quantifying scan parameter sensitivity of radiomic AI models, while identifying clinically significant parameter regions associated with improved cross-dataset robustness. We formulate a mixed-effects framework for quantifying the influence that clinically relevant acquisition parameters have on models performance, while accounting for subject-level random effects. We have applied our framework to lung cancer diagnosis in CT scans using two independent multicentre datasets (a public database and own-collected data) and several SoA architectures. To evaluate across-database reproducibility, CT parameters have been adjusted using the data collected and tested on the public set. The optimal configuration selected is the current of the X-ray tube >= 200 mA, spiral pitch <= 1.5, slice thickness <= 1.25 mm, which balances diagnostic quality with low radiation dose. These configuration push metrics from 0.79+-0.04 sensitivity, 0.47+-0.10 specificity in low quality scans to 0.90+-0.10 sensitivity, 0.79 +- 0.13 specificity in high quality ones.